Literature DB >> 8871773

Platelet serotonergic markers and Tridimensional Personality Questionnaire measures in a clinical sample.

E C Nelson1, C R Cloninger, T R Przybeck, J G Csernansky.   

Abstract

A group of patients with major depressive disorder, with and without comorbid obsessive-compulsive disorder, completed the Tridimensional Personality Questionnaire (TPQ). Harm Avoidance scores were found to be high compared to published age-matched norms and to display a significant positive correlation with Hamilton Depression Rating Scale scores. Platelet 125I-lysergic acid diethylamide (125I-LSD) and 3H-paroxetine binding Bmax values were measured to test Cloninger's hypothesis that Harm Avoidance scores would correlate significantly with measures of serotonergic function. A significant inverse correlation was found between Harm Avoidance scores and 125I-LSD Bmax values. Correlations between 3H-paroxetine Bmax values and TPQ scale scores were not significant. These results suggest an alternative view of the literature relating platelet 5-hydroxytryptamine-2a receptors and mood disorders in that the temperament dimension, Harm Avoidance, may explain prior inconsistencies involving links with depression and suicidality.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871773     DOI: 10.1016/0006-3223(95)00381-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  3 in total

Review 1.  Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry.

Authors:  Beatrice Alexandra Golomb; Michael H Criqui; Halbert White; Joel E Dimsdale
Journal:  Arch Intern Med       Date:  2004-01-26

2.  Novelty seeking and harm avoidance in Parkinson's disease: effects of asymmetric dopamine deficiency.

Authors:  R Tomer; J Aharon-Peretz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

Review 3.  The relevance of personality assessment in estimating the risk of onset and the outcome of major depressive disorder.

Authors:  Bogdan Nemes; Doina Cozman
Journal:  Clujul Med       Date:  2016-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.